Clinical Trial Update: Peanut Allergy Oral Immunotherapy Desensitization [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for peanut allergy oral immunotherapy desensitization completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peanut Allergy

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Peanut Allergy | Phase 2 | Status: COMPLETED